We are live on ! Find out more
NAMSW icon

NewAmsterdam Pharma Warrant
NAMSW

18 hedge funds and large institutions have $5.65M invested in NewAmsterdam Pharma Warrant in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more capital invested

Capital invested by funds: $3.49M → $5.65M (+$2.16M)

0.1% more ownership

Funds ownership: 1.9% → 2.01% (+0.1%)

0% more funds holding

Funds holding: 18 → 18 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
18
Holders Change
–
Holders Change %
0%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
1
Closed
2
Calls
$235K
Puts
–
Net Calls
+$235K
Net Calls Change
+$92K

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$35.9K

Top Sellers

Rank Fund Capital Flow
1
ETH
Exos TFP Holdings
New York
-$23.3K
2
CS
Clear Street
New York
-$8.75K
3
UBS Group
UBS Group
Switzerland
-$72
Name Holding Trade Value Shares
Change 		Change in
Stake
FLSM
1
Frazier Life Sciences Management
California
$1.57M – – –
RCM
2
RA Capital Management
Massachusetts
$1.04M – – –
EC
3
EcoR1 Capital
California
$745K – – –
Ensign Peak Advisors
4
Ensign Peak Advisors
Utah
$470K – – –
AAA
5
Affinity Asset Advisors
New York
$429K – – –
BCLSI
6
Bain Capital Life Sciences Investors
Massachusetts
$313K – – –
DM
7
Deerfield Management
New York
$290K – – –
ACM
8
ADAR1 Capital Management
Texas
$259K +$162K +82,857 New
WCMNY
9
Westchester Capital Management (New York)
New York
$97.6K – – –
HF
10
HRT Financial
New York
$94K – – –
Walleye Capital
11
Walleye Capital
New York
$70.9K – – –
Susquehanna International Group
12
Susquehanna International Group
Pennsylvania
$57.3K +$35.9K +18,319 New
PI
13
PEAK6 Investments
Illinois
$53.2K – – –
LCM
14
Laurion Capital Management
New York
$52.2K – – –
Walleye Trading
15
Walleye Trading
New York
$41K – – –
VI
16
Vestcor Inc
New Brunswick, Canada
$30K – – –
CS
17
Clear Street
New York
$28.1K -$8.75K -4,470 -33%
CG
18
Cutler Group
California
$15K – – –
ETH
19
Exos TFP Holdings
New York
– -$23.3K -12,273 Closed
UBS Group
20
UBS Group
Switzerland
– -$72 -38 Closed

NAMSW Hedge Fund Activity: Q4 2023 in Review

18 of the 6,862 institutional investors tracked by Wall St. Rank reported a position in NewAmsterdam Pharma Warrant (NAMSW) for Q4 2023, worth a combined $5.65M — up 62% from $3.49M a quarter earlier.

Fund positioning in NAMSW was balanced in Q4 2023: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 1 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $35.9K. The largest seller was Exos TFP Holdings, exiting entirely with an estimated $23.3K sold.

  • 18 institutional investors held NewAmsterdam Pharma Warrant (NAMSW) as of Q4 2023, unchanged from Q3 2023.
  • Funds reported $5.65M of NewAmsterdam Pharma Warrant stock for Q4 2023, up 62% quarter-over-quarter.
  • 2 funds opened new NewAmsterdam Pharma Warrant positions in Q4 2023 and 2 closed out, a net change of 0 holders.
  • The largest NewAmsterdam Pharma Warrant buyer in Q4 2023 was Susquehanna International Group, an estimated $35.9K added.
  • The largest NewAmsterdam Pharma Warrant seller in Q4 2023 was Exos TFP Holdings, an estimated $23.3K sold.

Based on aggregated 13F filings for Q4 2023.